ACT Genomics Co., Ltd. is a cancer molecular information service company based in Taipei City, Taiwan, with additional locations in Hong Kong, Singapore, and Japan. Established in 2014, the company specializes in transforming cancer genomic information into precision diagnostics and personalized treatment options. Through advanced technologies, including next-generation sequencing and bioinformatics tools, ACT Genomics offers comprehensive tumor profiling that identifies specific genetic alterations driving cancer pathogenesis and treatment responses. Their services include integrated genomic analysis, clinical reporting on genomic alterations and therapeutic implications, and profiling of cancer-related genes. Additionally, ACT Genomics assists in predicting responses to immunotherapy and monitoring tumor burden through circulating tumor DNA detection. The company's innovative approach aims to enhance the effectiveness of oncology treatment decisions, making personalized medicine more accessible and impactful.
Private Equity Round in 2008
Fulltech Fiber Glass Corp. produces and sells fiber glass yarn and fabrics in Taiwan. It offers electronic grade fiber glass yarn for use in the manufacture of fiber glass fabric, printed circuit boards, desktop and laptop computers, cellular phones, PDAs, and projection cloths, as well as industrial grade fiber glass yarn for use in the manufacture of insulation tubes. The company was founded in 1999 and is based in Taipei, Taiwan.